Paid Clinical Trials Colorado
Discover 1,629 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Asthma Research Study for Ages 12–17Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor:
AstraZeneca
Location:
Code:
NCT06307665
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
BDA MDI
AS MDI
NX-1607A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT05107674
Conditions
Ovarian Cancer, Epithelial
Gastric Cancer
GastroEsophageal Junction (GEJ) Cancer
Head and Neck Squamous Cell Carcinoma
Metastatic or Unresectable Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-1607
Paclitaxel
Harmony TPVHarmony TPV Post-Approval Study
Sponsor:
Medtronic Cardiovascular
Location:
Code:
NCT05077774
Conditions
Congenital Heart Disease
Tetrology of Fallot
RVOT Anomaly
Pulmonary Regurgitation
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Harmony TPV System
PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Sponsor:
89bio, Inc.
Location:
Code:
NCT06419374
Conditions
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Pegozafermin
Placebo
Symphony™ SystemEvaluation of Symphony™ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity
Sponsor:
International Spine Study Group Foundation
Location:
Code:
NCT04912674
Conditions
Cervical Deformity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Symphony OCT System
LitifilimabA 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)
Sponsor:
Biogen
Location:
Code:
NCT05531565
Conditions
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Litifilimab
Placebo
Olutasidenib & TemozolomideStudy of Olutasidenib and Temozolomide in HGG
Sponsor:
Rigel Pharmaceuticals
Location:
Code:
NCT06161974
Conditions
High Grade Glioma
Astrocytoma
Astrocytoma, Grade III
Astrocytoma, Grade IV
Diffuse Intrinsic Pontine Glioma
Eligibility Criteria
Sex: All
Age: 12 - 39
Healthy Volunteers: Not accepted
Interventions
Olutasidenib + TMZ
Observational StudySTXBP1 and SYNGAP1 Related Disorders Natural History Study
Sponsor:
Children's Hospital of Philadelphia
Location:
Code:
NCT06555965
Conditions
Genetic Disease
STXBP1 Encephalopathy With Epilepsy
SYNGAP1-Related Intellectual Disability
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Non-interventional study
Observational StudyUnderstanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women
Sponsor:
University of Colorado, Denver
Location:
Code:
NCT06441474
Conditions
Breast Cancer Female
Eligibility Criteria
Sex: Female
Age: 39 - 70+
Healthy Volunteers: Not accepted